Ataluren + Pembrolizumab
NL64152.018.18
Phase 2 small_molecule active
Quick answer
Ataluren + Pembrolizumab for Colorectal Cancer is a Phase 2 program (small_molecule) at PTC THERAPEUTICS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- PTC THERAPEUTICS, INC.
- Indication
- Colorectal Cancer
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active